跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
張 偉民
副教授
,
口腔衛生學系
https://orcid.org/0000-0002-6899-4043
電子郵件
weiminchang
tmu.edu
tw
h-index
940
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2026
每年研究成果
概覽
指紋
網路
專案
(5)
研究成果
(37)
資料集
(3)
類似的個人檔案
(6)
指紋
查看啟用 Wei-Min Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Mouth Squamous Cell Carcinoma
93%
Oral Cancer
93%
Head and Neck Squamous Cell Carcinoma
87%
Metastatic Carcinoma
69%
Head and Neck Cancer
58%
Malignant Neoplasm
48%
microRNA
43%
Upregulation
39%
Lung Adenocarcinoma
39%
Cancer Growth
38%
down Regulation
38%
Proteomics
37%
Squamous Cell Carcinoma Cell
29%
Cancer Cell
29%
Signal Transduction
28%
Lung Cancer
26%
Cytotoxicity
26%
Programmed Cell Death
25%
Neoplasm
25%
Catenin
24%
Lymph Node Metastasis
21%
Non Small Cell Lung Cancer
21%
Carcinogen
21%
Circulating microRNA
18%
Nodular Melanoma
18%
Cell Growth
18%
Absence
18%
Hepatocellular Carcinoma
18%
Activin A
18%
Long Untranslated RNA
18%
Genetic Variability
18%
Prasterone
18%
Irinotecan
18%
Tumor-Associated Glycoprotein 72
18%
Iron Balance
18%
Colorectal Cancer
18%
Receptor
18%
Lung Metastasis
18%
Glucose Transporter 4
18%
Timbetasin
18%
Gelatinase B
18%
Ceruloplasmin
18%
Hypoxia Inducible Factor 1
18%
Parathyroid Hormone
18%
Fas Ligand
18%
Sulfotransferase
18%
Cellular Infiltration
18%
Cell Activation
18%
T Cell
18%
Fibroblast
18%
Biochemistry, Genetics and Molecular Biology
MicroRNA
65%
down Regulation
57%
Cancer Cell
45%
Upregulation
45%
STAT3
43%
Epidermal Growth Factor Receptor
40%
Proteomics
37%
RUNX2
37%
PD-L1
37%
Catenin
34%
Signal Transduction
34%
Overall Survival
33%
Piper Betle
28%
Cell Growth
28%
STAT1
23%
Dehydroepiandrosterone
18%
Genetic Divergence
18%
Aldo-Keto Reductase
18%
Thymosin Beta-4
18%
Genotyping
18%
TXNIP
18%
Iron Balance
18%
JAG1
18%
Cisplatin
18%
GLUT4
18%
Activin
18%
IDH1
18%
Glucose Transporter
18%
Hypoxia Inducible Factor 1
18%
Proteoglycan
18%
Parathyroid Hormone
18%
Ceruloplasmin
18%
Sulfotransferase
18%
Ferroxidase
18%
MMP9
18%
Gelatinase B
18%
Cell Death
18%
Eicosanoid Receptor
18%
Long Non-Coding RNA
18%
Immune Response
18%
Fibroblast
18%
Lipocalin-2
18%
Sapindus
18%
Computer Model
16%
Aldolase A
16%
Disease Free Survival
16%
Mesenchymal-Epithelial Transition
15%
Cell Viability
15%
Messenger RNA
14%
Single-Nucleotide Polymorphism
14%
Pharmacology, Toxicology and Pharmaceutical Science
Mouth Squamous Cell Carcinoma
100%
Mouth Cancer
76%
Head and Neck Squamous Cell Carcinoma
73%
Malignant Neoplasm
48%
microRNA
43%
Head and Neck Cancer
41%
Gelatinase B
37%
Cancer Growth
37%
Neoplasm
35%
Metastasis
23%
Lung Cancer
22%
Non Small Cell Lung Cancer
21%
Lymph Node Metastasis
19%
Ceruloplasmin
18%
Lung Metastasis
18%
Liver Cell Carcinoma
18%
Activin A
18%
Timbetasin
18%
Silymarin
18%
Prasterone
18%
Antimetastatic Agent
18%
Aldo Keto Reductase
18%
Glycoprotein
18%
Receptor
18%
Colorectal Cancer
18%
Norcantharidin
18%
Cirsium
18%
Irinotecan
18%
C57BL Mouse
18%
Cisplatin
18%
Hypoxia Inducible Factor 1
18%
Sulfotransferase
18%
Fas Ligand
18%
Tacrine
18%
Inflammation
18%
Neutrophil Gelatinase Associated Lipocalin
18%
Biological Marker
16%
Fructose Bisphosphate Aldolase
16%
Inflammatory Disease
12%
Catenin
11%
Luciferase
9%
Suppressor of Cytokine Signaling
9%
Suppressor of Cytokine Signaling 2
9%
Antagomir
9%
Disease
8%
Recurrent Disease
8%
Phenol
7%
C57BL 6 Mouse
7%
Hepatoprotection
7%
Overall Survival
7%
